Why Novavax Stock Jumped 6.5% Higher Today
Monday was an up day for Novavax (NASDAQ: NVAX), one of the more volatile coronavirus stocks on the scene. Its shares rose by 6.5% on the back of some regulatory news in a major overseas market.
On Monday morning, Novavax and manufacturer Serum Institute of India announced that an Emergency Use Authorization (EUA) submission had been filed with the South African Health Products Regulatory Agency (SAHPRA) for NVX-CoV2373, the company's coronavirus vaccine. If the EUA is approved, NVX-CoV2373 would be branded and distributed there as Covovax.
Image source: Getty Images.
Source Fool.com
